Daily Memo: Another Vaccine Candidate

The one from Moderna is the second to come out of the West.

587

Another vaccine candidate. On Monday, U.S. biotech firm Moderna announced that its COVID-19 vaccine candidate had shown 94.5 percent effectiveness in clinical trials, making it the second Western vaccine candidate on track for approval in the coming months. RCEP finally signed. Trade ministers from 15 Asia-Pacific nations signed the world’s largest trade pact – the […]

This article is for subscribers only

Join thousands of readers who rely on GPF for clear-eyed geopolitical analysis.

$79 per year Save 27% vs. monthly
Full access to all daily analysis & forecasts
George Friedman's geopolitical insights
2026 Forecast & Special Collection on the Middle East
100% reader-supported
Subscribe Now

30-day money-back guarantee


Already a subscriber? Log in